Cargando…
Abrogation of TNFα Production during Cancer Immunotherapy Is Crucial for Suppressing Side Effects Due to the Systemic Expression of IL-12
For more than a decade, the cytokine interleukin-12 (IL-12) has been utilized, either alone or in combination with other drugs, as a treatment for cancer. The numerous anti-tumor properties of IL-12 still generate interest in the clinical use of this cytokine, even though it has demonstrated toxicit...
Autores principales: | Barrios, Bibiana, Baez, Natalia S., Reynolds, Della, Iribarren, Pablo, Cejas, Hugo, Young, Howard A., Rodriguez-Galan, Maria Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938584/ https://www.ncbi.nlm.nih.gov/pubmed/24587231 http://dx.doi.org/10.1371/journal.pone.0090116 |
Ejemplares similares
-
Uncovering the dark side of TNF
por: Bashyam, Hema
Publicado: (2007) -
The dark side of immunotherapy: pancreatic cancer
por: Mucciolo, Gianluca, et al.
Publicado: (2020) -
Leflunomide abrogates neuroinflammatory changes in a rat model of Alzheimer’s disease: the role of TNF-α/NF-κB/IL-1β axis inhibition
por: Nafea, Menna, et al.
Publicado: (2022) -
Temozolomide abrogates the aggressiveness of urothelial carcinoma cells by enhancing senescence and depleting the side population
por: Kim, Na-Yon, et al.
Publicado: (2021) -
A Rare Side Effect due to TNF-Alpha Blocking Agent: Acute Pleuropericarditis with Adalimumab
por: Ozkan, Hakan, et al.
Publicado: (2013)